From: Pharmacodynamics and pharmacokinetics of a new type of recombinant insulin Lisargine injection
Samples | N = 1 | N = 2 | N = 3 | Mean ± SEM | P value | |
---|---|---|---|---|---|---|
IC50 (nM) | IC50 (nM) | IC50 (nM) | vs. S-Insulin | Lantus vs. Lisargine | ||
S-Insulin | 0.93 | 0.82 | 0.79 | 0.82 ± 0.02 | / | / |
Lantus | 0.82 | 0.65 | 0.30 | 0.50 ± 0.09 | 0.180 | / |
H-Insulin | 0.76 | 0.51 | 0.49 | 0.54 ± 0.04 | 0.058 | / |
Lisargine | 0.69 | 0.74 | 0.32 | 0.52 ± 0.09 | 0.135 | 0.990 |